Skip to main content
Premium Trial:

Request an Annual Quote

Oncormed Completes Private Placement

Premium

GAITHERSBURG, Md.--Genomics services company Oncormed completed a $3 million equity financing through a private placement of convertible preferred stock to certain investors. Subject to certain conditions, the company and investors have the right to increase the aggregate amount of equity financing by an additional $3 million for an aggregate investment of $6 million. Oncormed characterizes genes to establish their clinical relevance and provides molecular profiling of patients for pharmacogenomic and therapeutic purposes.

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.